These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 30400055)
1. French Endocrine Society Guidance on endocrine side effects of immunotherapy. Castinetti F; Albarel F; Archambeaud F; Bertherat J; Bouillet B; Buffier P; Briet C; Cariou B; Caron P; Chabre O; Chanson P; Cortet C; Do Cao C; Drui D; Haissaguerre M; Hescot S; Illouz F; Kuhn E; Lahlou N; Merlen E; Raverot V; Smati S; Verges B; Borson-Chazot F Endocr Relat Cancer; 2019 Feb; 26(2):G1-G18. PubMed ID: 30400055 [TBL] [Abstract][Full Text] [Related]
2. [Immunotherapy-induced endocrinopathies: Insights from the 2018 French Endocrine Society Guidelines]. Castinetti F; Borson-Chazot F Bull Cancer; 2019 May; 106(5):492-496. PubMed ID: 30981462 [TBL] [Abstract][Full Text] [Related]
3. Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints. Chang LS; Barroso-Sousa R; Tolaney SM; Hodi FS; Kaiser UB; Min L Endocr Rev; 2019 Feb; 40(1):17-65. PubMed ID: 30184160 [TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors and endocrine side effects, a narrative review. Agrawal L; Bacal A; Jain S; Singh V; Emanuele N; Emanuele M; Meah F Postgrad Med; 2020 Mar; 132(2):206-214. PubMed ID: 31876444 [TBL] [Abstract][Full Text] [Related]
5. Introduction to expert opinion on endocrine complications of new anticancer therapies. Castinetti F; Borson-Chazot F Ann Endocrinol (Paris); 2018 Oct; 79(5):535-538. PubMed ID: 30056976 [TBL] [Abstract][Full Text] [Related]
6. Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions. Castinetti F; Albarel F; Archambeaud F; Bertherat J; Bouillet B; Buffier P; Briet C; Cariou B; Caron P; Chabre O; Chanson P; Cortet C; Do Cao C; Drui D; Haissaguerre M; Hescot S; Illouz F; Kuhn E; Lahlou N; Merlen E; Raverot V; Smati S; Verges B; Borson-Chazot F Ann Endocrinol (Paris); 2018 Oct; 79(5):591-595. PubMed ID: 30056975 [TBL] [Abstract][Full Text] [Related]
17. Management of Immune Checkpoint Inhibitor Toxicities: A Review and Clinical Guideline for Emergency Physicians. Hryniewicki AT; Wang C; Shatsky RA; Coyne CJ J Emerg Med; 2018 Oct; 55(4):489-502. PubMed ID: 30120013 [TBL] [Abstract][Full Text] [Related]
18. Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know). Ruggeri RM; Campennì A; Giuffrida G; Trimboli P; Giovanella L; Trimarchi F; Cannavò S J Endocrinol Invest; 2019 Jul; 42(7):745-756. PubMed ID: 30471004 [TBL] [Abstract][Full Text] [Related]
19. Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database. Sato K; Mano T; Iwata A; Toda T J Neurooncol; 2019 Oct; 145(1):1-9. PubMed ID: 31452071 [TBL] [Abstract][Full Text] [Related]
20. Endocrine side effects of cancer immunotherapy. Cukier P; Santini FC; Scaranti M; Hoff AO Endocr Relat Cancer; 2017 Dec; 24(12):T331-T347. PubMed ID: 29025857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]